Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for CSTL

Stock NameCastle Biosciences Inc
TickerCSTL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS14843C1053

Show aggregate CSTL holdings

News associated with CSTL

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of “Moderate Buy” by Brokerages
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price objective among brokerages […] - 2025-09-04 02:46:48
Mackenzie Financial Corp Has $550,000 Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)
Mackenzie Financial Corp boosted its holdings in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 30.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,460 shares of the company’s stock after buying an additional 6,440 shares during the period. Mackenzie Financial Corp […] - 2025-08-08 05:02:56
Castle Biosciences (NASDAQ:CSTL) Shares Gap Up Following Earnings Beat
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) shares gapped up prior to trading on Tuesday following a better than expected earnings announcement. The stock had previously closed at $15.32, but opened at $19.85. Castle Biosciences shares last traded at $21.06, with a volume of 249,752 shares traded. The company reported $0.15 EPS for the […] - 2025-08-07 02:13:00
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Shares in Castle Biosciences, Inc. (NASDAQ:CSTL)
Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 1st quarter, HoldingsChannel.com reports. The fund purchased 11,753 shares of the company’s stock, valued at approximately $235,000. A number of other institutional investors have also added to or reduced their stakes in CSTL. Allianz Asset Management […] - 2025-08-05 04:38:48
Envestnet Asset Management Inc. Has $1.40 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)
Envestnet Asset Management Inc. decreased its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 4.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 69,771 shares of the company’s stock after selling 3,573 shares during the quarter. Envestnet Asset Management Inc. owned […] - 2025-08-01 05:01:11
GSA Capital Partners LLP Sells 3,658 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
GSA Capital Partners LLP decreased its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 5.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 67,143 shares of the company’s stock after selling 3,658 shares during the period. GSA Capital Partners LLP owned about 0.23% of […] - 2025-07-31 05:32:57
Stephens Inc. AR Sells 800 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Stephens Inc. AR cut its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 5.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 13,639 shares of the company’s stock after selling 800 shares during the period. Stephens Inc. AR’s holdings in Castle Biosciences were worth $273,000 as of its most recent filing […] - 2025-07-21 05:10:45
Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $37.00
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given an average rating of “Buy” by the eight brokerages that are currently covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock in the […] - 2025-06-24 02:16:45
Two Sigma Advisers LP Takes Position in Castle Biosciences, Inc. (NASDAQ:CSTL)
Two Sigma Advisers LP acquired a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund acquired 11,500 shares of the company’s stock, valued at approximately $306,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Covestor Ltd acquired […] - 2025-06-06 05:12:48
Squarepoint Ops LLC Trims Position in Castle Biosciences, Inc. (NASDAQ:CSTL)
Squarepoint Ops LLC trimmed its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 51.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,317 shares of the company’s stock after selling 18,142 shares during the period. Squarepoint Ops LLC’s holdings in Castle Biosciences were […] - 2025-06-05 05:04:48
Public Employees Retirement System of Ohio Lowers Stake in Castle Biosciences, Inc. (NASDAQ:CSTL)
Public Employees Retirement System of Ohio lowered its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 16.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 74,132 shares of the company’s stock after selling 14,776 shares […] - 2025-06-02 05:34:54
Man Group plc Buys Shares of 13,302 Castle Biosciences, Inc. (NASDAQ:CSTL)
Man Group plc bought a new stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 13,302 shares of the company’s stock, valued at approximately $354,000. Several other hedge funds have also recently made changes […] - 2025-05-27 05:34:50
Nuveen Asset Management LLC Has $12.41 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL)
Nuveen Asset Management LLC lowered its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 14.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 465,526 shares of the company’s stock after selling 77,067 shares during the period. Nuveen Asset Management LLC’s holdings in […] - 2025-05-27 04:44:54
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Rating of “Buy” from Analysts
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have received an average recommendation of “Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Eight equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have updated their coverage on […] - 2025-05-27 02:32:56
D. E. Shaw & Co. Inc. Makes New $2.41 Million Investment in Castle Biosciences, Inc. (NASDAQ:CSTL)
D. E. Shaw & Co. Inc. acquired a new position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 90,563 shares of the company’s stock, valued at approximately $2,414,000. Other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & […] - 2025-05-21 05:44:54
Ameriprise Financial Inc. Sells 33,193 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Ameriprise Financial Inc. trimmed its holdings in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 316,036 shares of the company’s stock after selling 33,193 shares during the quarter. Ameriprise Financial Inc.’s […] - 2025-05-21 04:28:51
Castle Biosciences, Inc. (NASDAQ:CSTL) Stake Cut by Jane Street Group LLC
Jane Street Group LLC cut its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 59.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 59,383 shares of the company’s stock after selling 86,001 shares during the quarter. Jane Street Group […] - 2025-05-19 04:56:50
Schonfeld Strategic Advisors LLC Sells 40,700 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Schonfeld Strategic Advisors LLC cut its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 72.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 15,300 shares of the company’s stock after selling 40,700 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in Castle Biosciences were worth $408,000 as of […] - 2025-05-12 05:42:51
Wells Fargo & Company MN Buys 3,460 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Wells Fargo & Company MN lifted its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 29.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,375 shares of the company’s stock after acquiring an additional 3,460 shares during the period. Wells […] - 2025-05-05 04:23:03
CANADA LIFE ASSURANCE Co Sells 2,506 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
CANADA LIFE ASSURANCE Co trimmed its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 19.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,713 shares of the company’s stock after selling 2,506 shares during the quarter. CANADA LIFE ASSURANCE Co’s holdings […] - 2025-05-01 05:40:55
LPL Financial LLC Sells 3,421 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
LPL Financial LLC decreased its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 12.9% in the 4th quarter, Holdings Channel reports. The fund owned 23,043 shares of the company’s stock after selling 3,421 shares during the quarter. LPL Financial LLC’s holdings in Castle Biosciences were worth $614,000 as of its most […] - 2025-04-24 04:16:59
ExodusPoint Capital Management LP Sells 32,779 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
ExodusPoint Capital Management LP cut its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 74.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 11,484 shares of the company’s stock after selling 32,779 shares during the period. ExodusPoint Capital Management LP’s holdings in Castle Biosciences were […] - 2025-04-14 05:58:59
Corebridge Financial Inc. Sells 972 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Corebridge Financial Inc. lessened its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,860 shares of the company’s stock after selling 972 shares during the quarter. Corebridge Financial Inc.’s holdings in Castle Biosciences […] - 2025-04-11 04:54:48
Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $38.75
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given a consensus rating of “Buy” by the eight brokerages that are currently covering the company, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the stock […] - 2025-04-10 03:07:07
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Sei Investments Co.
Sei Investments Co. lifted its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 9.6% during the 4th quarter, HoldingsChannel reports. The fund owned 41,491 shares of the company’s stock after acquiring an additional 3,617 shares during the period. Sei Investments Co.’s holdings in Castle Biosciences were worth $1,106,000 at the end […] - 2025-04-08 04:31:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Intech Investment Management LLC
Intech Investment Management LLC increased its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 39.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,578 shares of the company’s stock after purchasing an additional 3,294 shares during the quarter. Intech Investment […] - 2025-03-26 06:23:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of “Buy” by Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have earned an average rating of “Buy” from the seven research firms that are covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued ratings on the stock in […] - 2025-03-13 04:20:58
Rhumbline Advisers Reduces Stake in Castle Biosciences, Inc. (NASDAQ:CSTL)
Rhumbline Advisers reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,892 shares of the company’s stock after selling 1,009 shares during the quarter. Rhumbline Advisers’ holdings in […] - 2025-03-06 07:53:36
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $40.29 Consensus Target Price from Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are presently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have covered the stock […] - 2025-02-21 05:11:00
R Squared Ltd Acquires Shares of 1,590 Castle Biosciences, Inc. (NASDAQ:CSTL)
R Squared Ltd acquired a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,590 shares of the company’s stock, valued at approximately $42,000. Other institutional investors and […] - 2025-02-03 06:49:05

iShares Healthcare Innovation UCITS ETF USD (Acc) CSTL holdings

DateNumber of CSTL Shares HeldBase Market Value of CSTL SharesLocal Market Value of CSTL SharesChange in CSTL Shares HeldChange in CSTL Base ValueCurrent Price per CSTL Share HeldPrevious Price per CSTL Share Held
2025-11-12 (Wednesday)35,553USD 1,237,955USD 1,237,955
2025-11-11 (Tuesday)35,553USD 1,243,288CSTL holding increased by 8177USD 1,243,2880USD 8,177 USD 34.97 USD 34.74
2025-11-10 (Monday)35,553USD 1,235,111CSTL holding increased by 60440USD 1,235,1110USD 60,440 USD 34.74 USD 33.04
2025-11-07 (Friday)35,553USD 1,174,671CSTL holding decreased by -18132USD 1,174,6710USD -18,132 USD 33.04 USD 33.55
2025-11-06 (Thursday)35,553USD 1,192,803CSTL holding decreased by -711USD 1,192,8030USD -711 USD 33.55 USD 33.57
2025-11-05 (Wednesday)35,553USD 1,193,514CSTL holding increased by 68973USD 1,193,5140USD 68,973 USD 33.57 USD 31.63
2025-11-04 (Tuesday)35,553USD 1,124,541CSTL holding increased by 200519USD 1,124,5410USD 200,519 USD 31.63 USD 25.99
2025-11-03 (Monday)35,553USD 924,022CSTL holding increased by 17420USD 924,0220USD 17,420 USD 25.99 USD 25.5
2025-10-31 (Friday)35,553USD 906,602CSTL holding increased by 45864USD 906,6020USD 45,864 USD 25.5 USD 24.21
2025-10-30 (Thursday)35,553USD 860,738CSTL holding increased by 16710USD 860,7380USD 16,710 USD 24.21 USD 23.74
2025-10-29 (Wednesday)35,553USD 844,028CSTL holding decreased by -14577USD 844,0280USD -14,577 USD 23.74 USD 24.15
2025-10-28 (Tuesday)35,553USD 858,605CSTL holding increased by 6755USD 858,6050USD 6,755 USD 24.15 USD 23.96
2025-10-27 (Monday)35,553USD 851,850CSTL holding decreased by -19554USD 851,8500USD -19,554 USD 23.96 USD 24.51
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CSTL by Blackrock for IE00BYZK4776

Show aggregate share trades of CSTL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-24SELL-30424.51024.860 24.825USD -7,547 22.98 Loss of -562 on sale
2025-09-11BUY15322.75023.570 23.488USD 3,594 23.00
2025-07-08SELL-15219.76019.860 19.850USD -3,017 23.32 Profit of 528 on sale
2025-06-24SELL-15619.16019.300 19.286USD -3,009 23.54 Profit of 664 on sale
2025-06-23SELL-15618.85018.920 18.913USD -2,950 23.58 Profit of 727 on sale
2025-06-20BUY3,80318.52019.175 19.109USD 72,673 23.61
2025-06-11SELL-13818.44018.670 18.647USD -2,573 23.87 Profit of 721 on sale
2025-05-30SELL-13915.97016.060 16.051USD -2,231 24.32 Profit of 1,149 on sale
2025-05-21BUY13916.02016.480 16.434USD 2,284 24.82
2025-05-14SELL-82816.32017.090 17.013USD -14,087 25.12 Profit of 6,715 on sale
2025-04-30SELL-13720.05020.120 20.113USD -2,755 25.84 Profit of 784 on sale
2025-04-28SELL-13720.09020.820 20.747USD -2,842 25.95 Profit of 713 on sale
2025-04-25SELL-13720.63020.860 20.837USD -2,855 26.01 Profit of 709 on sale
2025-04-11SELL-84019.70020.045 20.011USD -16,809 26.44 Profit of 5,402 on sale
2025-04-08SELL-41718.60020.100 19.950USD -8,319 26.69 Profit of 2,809 on sale
2025-04-07SELL-29619.09019.965 19.878USD -5,884 26.77 Profit of 2,041 on sale
2025-03-31SELL-27820.02020.300 20.272USD -5,636 27.12 Profit of 1,904 on sale
2025-03-21SELL-27620.52021.010 20.961USD -5,785 27.65 Profit of 1,847 on sale
2025-03-12SELL-14219.63020.490 20.404USD -2,897 28.45 Profit of 1,142 on sale
2025-02-28SELL-14021.68026.000 25.568USD -3,580 29.46 Profit of 545 on sale
2025-02-25BUY14025.09025.360 25.333USD 3,547 29.67
2025-02-20SELL-14026.15027.180 27.077USD -3,791 29.88 Profit of 392 on sale
2025-02-19BUY28027.19027.565 27.528USD 7,708 29.93
2025-02-18BUY14026.72027.800 27.692USD 3,877 29.99
2024-12-30SELL-26626.66026.790 26.777USD -7,123 31.45 Profit of 1,242 on sale
2024-12-06SELL-13631.19032.600 32.459USD -4,414 31.53 Loss of -126 on sale
2024-12-04SELL-13631.88032.220 32.186USD -4,377 31.50 Loss of -94 on sale
2024-12-03SELL-27230.78031.380 31.320USD -8,519 31.52 Profit of 55 on sale
2024-11-21SELL-13928.88029.705 29.622USD -4,118 32.10 Profit of 344 on sale
2024-11-20SELL-14528.45028.800 28.765USD -4,171 32.30 Profit of 512 on sale
2024-11-19SELL-14528.87029.020 29.005USD -4,206 32.50 Profit of 507 on sale
2024-11-18SELL-54827.90028.820 28.728USD -15,743 32.79 Profit of 2,224 on sale
2024-11-12SELL-13732.78034.640 34.454USD -4,720 32.79 Loss of -228 on sale
2024-11-07SELL-13733.31034.040 33.967USD -4,653 32.71 Loss of -172 on sale
2024-11-05SELL-27231.15035.840 35.371USD -9,621 32.85 Loss of -684 on sale
2024-10-28SELL-13732.40033.160 33.084USD -4,533 31.84 Loss of -170 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CSTL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19118,6580203,89058.2%
2025-09-1886,6930206,73941.9%
2025-09-1727,039677,52134.9%
2025-09-1649,9730213,49023.4%
2025-09-1539,2460306,41512.8%
2025-09-1235,3912588,19340.1%
2025-09-1138,0300102,19337.2%
2025-09-1053,5220150,49135.6%
2025-09-0962,336193,44466.7%
2025-09-0855,93210194,95658.9%
2025-09-0543,845067,69664.8%
2025-09-0454,0739,081123,43743.8%
2025-09-03118,250292218,15554.2%
2025-09-02172,9384,866229,11675.5%
2025-08-29123,5080164,41775.1%
2025-08-28172,3590231,07574.6%
2025-08-27246,6817,090407,34260.6%
2025-08-26122,9080161,30276.2%
2025-08-2566,0640106,76961.9%
2025-08-2285,9630114,43275.1%
2025-08-2137,391056,08766.7%
2025-08-2055,0091793,76358.7%
2025-08-1932,6240103,24031.6%
2025-08-1834,96860085,74440.8%
2025-08-1569,817403151,95745.9%
2025-08-1473,1270199,06136.7%
2025-08-13645,5336251,181,13054.7%
2025-08-12120,9060187,67664.4%
2025-08-1156,0510132,77142.2%
2025-08-0862,7000231,88727.0%
2025-08-07121,02124333,24936.3%
2025-08-06164,0784488,86233.6%
2025-08-05238,600915767,44731.1%
2025-08-0488,1000384,56222.9%
2025-08-0166,0300114,01257.9%
2025-07-3183,71111144,23758.0%
2025-07-3043,5500132,03233.0%
2025-07-2942,809079,02754.2%
2025-07-2832,280814104,20431.0%
2025-07-2533,072082,33140.2%
2025-07-2450,2490111,61245.0%
2025-07-2358,5790129,45945.2%
2025-07-2259,718404155,28138.5%
2025-07-2192,01329192,03947.9%
2025-07-1882,4900165,41549.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.